LIJENTA 5 mg contains Linagliptin 5 mg. It is an oral antidiabetic medicine belonging to the DPP-4 inhibitor class, used to control blood glucose levels in patients with type 2 diabetes mellitus by improving insulin regulation.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps improve blood glucose control along with diet and exercise
-
Used when lifestyle changes alone are not sufficient to control blood sugar levels
-
May be used alone or in combination with other antidiabetic medicines as prescribed
Dose:
-
Adults: Usually 5 mg once daily, or as directed by a physician
-
Take the medicine with or without food
-
Dose adjustment is generally not required for mild to severe kidney impairment, but medical supervision is recommended
-
Do not stop or change the dose without medical advice
-
Regular blood glucose monitoring is recommended during treatment